v3.25.2
Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Operating expenses:        
Research and development $ 101,177 $ 97,746 $ 196,766 $ 181,593
General and administrative 22,409 36,711 50,395 84,765
Total operating expenses 123,586 134,457 247,161 266,358
Loss from operations (123,586) (134,457) (247,161) (266,358)
Other income (expense):        
Interest expense (516) (562) (1,044) (1,134)
Interest income 8,940 12,016 18,709 24,081
Other income (expense) 464 50 375 (170)
Total other income 8,888 11,504 18,040 22,777
Net loss (114,698) (122,953) (229,121) (243,581)
Less: Net income attributable to non-controlling interest, net of tax of $0 0 22 0 42
Net loss attributable to common stockholders (114,698) (122,975) (229,121) (243,623)
Net loss (114,698) (122,953) (229,121) (243,581)
Other comprehensive income (loss):        
Unrealized gain (loss) on marketable securities (213) 868 (541) 2,358
Total comprehensive loss (114,911) (122,085) (229,662) (241,223)
Less: Comprehensive income attributable to non-controlling interest 0 22 0 42
Comprehensive loss attributable to common stockholders $ (114,911) $ (122,107) $ (229,662) $ (241,265)
Net loss per share - Basic $ (0.2) $ (0.25) $ (0.41) $ (0.49)
Net loss per share - Diluted $ (0.2) $ (0.25) $ (0.41) $ (0.49)
Weighted-average common shares outstanding - Basic 561,698 501,232 554,890 498,688
Weighted-average common shares outstanding - Diluted 561,698 501,232 554,890 498,688